| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 142,028 | 151,856 | 116,650 | 150,995 |
| Restricted cash | 23,977 | 26,134 | 23,689 | 24,368 |
| Accounts receivable, net | 314,158 | 309,861 | 386,564 | 358,756 |
| Prepaid expenses and other current assets | 21,847 | 18,521 | 22,228 | 28,138 |
| Assets held for sale - current | NaN | NaN | 20,963 | NaN |
| Total current assets | 502,010 | 506,372 | 570,094 | 562,257 |
| Restricted cash | 2,739 | 2,706 | 2,665 | 2,607 |
| Investments and equity method investees | 8,955 | 8,966 | 8,936 | 8,978 |
| Property and equipment, net | 81,181 | 80,785 | 80,086 | 77,273 |
| Right-of-use assets - operating | 3,866 | 4,373 | 4,837 | 5,342 |
| Prepaid expenses and other noncurrent assets | 2,250 | 3,078 | 2,938 | 4,081 |
| Contract cost assets | 13,731 | 13,537 | 11,160 | 12,504 |
| Intangible assets, net | 569,682 | 584,937 | 623,693 | 651,169 |
| Goodwill | 694,433 | 694,482 | 1,075,376 | 1,137,321 |
| Assets held for sale - noncurrent | NaN | NaN | 73,674 | NaN |
| Total assets | 1,878,847 | 1,899,236 | 2,453,459 | 2,461,532 |
| Accounts payable | 63,007 | 59,776 | 72,180 | 69,460 |
| Short-term debt, net | NaN | 0 | 5,118 | 172,119 |
| Accrued liabilities | 45,063 | 65,755 | 60,893 | 63,886 |
| Operating lease liability - current | 8,779 | 15,343 | 17,942 | 24,208 |
| Accrued compensation and employee benefits | 31,007 | 50,987 | 55,380 | 38,262 |
| Deferred revenue | 1,417 | 1,203 | 1,871 | 2,333 |
| Reserve for claims and performance - based arrangements | 231,962 | 192,196 | 211,652 | 187,251 |
| Liabilities held for sale - current | NaN | NaN | 4,891 | NaN |
| Total current liabilities | 381,235 | 385,260 | 429,927 | 557,519 |
| Long-term debt, net | 973,486 | 970,537 | 1,054,822 | 648,455 |
| Other long-term liabilities | 8,091 | 8,012 | 3,784 | 3,787 |
| Tax receivables agreement liability | 108,909 | 108,909 | 108,105 | 108,105 |
| Operating lease liabilities - noncurrent | 3,160 | 3,818 | 4,433 | 8,411 |
| Deferred tax liabilities, net | 7,573 | 7,506 | 10,155 | 10,450 |
| Total liabilities | 1,482,454 | 1,484,042 | 1,611,226 | 1,336,727 |
| Class a common stock - 0.01 par value 750,000,000 shares authorized 118,449,473 and 117,603,806 shares issued, respectively | 1,185 | 1,176 | 1,176 | 1,175 |
| Additional paid-in-capital | 1,802,222 | 1,793,398 | 1,791,060 | 1,782,992 |
| Accumulated other comprehensive loss | -3,626 | -2,624 | -2,376 | -1,707 |
| Retained earnings (accumulated deficit) | -1,341,959 | -1,315,327 | -886,196 | -865,332 |
| Treasury stock, at cost 5,971,712 and 5,971,712 shares issued, respectively | 61,429 | 61,429 | 61,431 | 21,123 |
| Total shareholders equity | 396,393 | 415,194 | 842,233 | 896,005 |
| Preferred class a common stock - 0.01 par value 50,000,000 shares authorized 175,000 issued, respectively | NaN | NaN | NaN | 228,800 |
| Total liabilities and shareholders equity | 1,878,847 | 1,899,236 | 2,453,459 | 2,461,532 |
Evolent Health, Inc. (EVH)
Evolent Health, Inc. (EVH)